Skip to main content
. 2012 Dec 14;43(6):1161–1173. doi: 10.1017/S0033291712002127

Table 1.

Sample characteristics of intent-to-treat (ITT) participants at baseline

CR (n = 26) TAU (n = 27) Difference (F2) First-episode depression (n = 20) First-episode psychosis (n = 33) Difference (F2)
Sample
 Male: Female 12:14 16:11 n.s. 8:12 20:13 n.s.
 First-episode depression 10 (38.5) 10 (37.0) n.s.
 First-episode psychosis 16 (61.5) 17 (63.0) n.s.
Demographic characteristics
 Age (years) 22.88 ± 4.0 22.74 ± 4.7 n.s. 22.00 ± 4.9 23.30 ± 3.9 n.s.
 Age of onset (years) 19.00 ± 3.9 18.08 ± 4.7 n.s. 16.41 ± 2.9 19.66 ± 4.5 7.08*
 Years of education 12.46 ± 1.8 12.63 ± 2.3 n.s. 12.45 ± 1.7 12.61 ± 2.3 n.s.
 Predicted IQ a 100.85 ± 9.4 104.31 ± 7.0 n.s. 106.10 ± 7.1 100.38 ± 8.5 6.33*
 General knowledge (z score) b 0.58 ± 1.0 0.81 ± 0.8 n.s. 0.93 ± 0.9 0.56 ± 0.9 n.s.
Clinical characteristics
 HAMD-17 10.65 ± 6.4 8.59 ± 6.6 n.s. 12.70 ± 7.5 7.73 ± 5.1 8.23**
 BPRS-E 37.35 ± 7.6 35.70 ± 10.4 n.s. 35.55 ± 7.6 37.09 ± 9.9 n.s.
 SFS-Total 106.89 ± 7.6 108.71 ± 6.9 n.s. 108.69 ± 5.4 107.29 ± 8.2 n.s.
Medication use
 Medications 22 (84.6) 22 (81.5) n.s. 12 (60.0) 32 (97.0) 12.07***
 Antidepressants 10 (38.5) 10 (37.0) n.s. 9 (45.0) 11 (33.3) n.s.
 Antipsychotics 15 (57.7) 17 (63.0) n.s. 3 (15.0) 29 (87.9) 27.65***
 Haloperidol dose equivalence (mg) c 3.28 ± 3.1 4.18 ± 3.1 n.s. 0.83 ± 1.2 4.46 ± 3.0 11.04**
 Benztropine dose equivalence (mg) d 4.35 ± 14.6 4.50 ± 15.4 n.s. 0.07 ± 0.1 6.19 ± 17.4 n.s.

CR, Cognitive remediation; TAU, treatment as usual; HAMD-17, 17-item Hamilton Depression Rating Scale; BPRS-E, Brief Psychiatric Rating Scale – Expanded; SFS, Social Functioning Scale; n.s., not significant.

Values given as n (%) or mean ± s.d.

a

Wechsler (2001) .

b

Information subtest (Wechsler, 1997a).

c

Based on conversion table in Kane et al. (2003) .

d

Based on conversion table in Minzenberg et al. (2004) .

*p ⩽ 0.05, **p ⩽ 0.01, ***p ⩽ 0.001.